111 related articles for article (PubMed ID: 25834338)
21. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer.
Tanaka M; Kitajima Y; Edakuni G; Sato S; Miyazaki K
Br J Surg; 2002 Feb; 89(2):236-44. PubMed ID: 11856141
[TBL] [Abstract][Full Text] [Related]
22. [Association of prognosis with insulin-like growth factor receptor type I expression in gastric cancer patients: a meta-analysis].
Gao Y; Cui J; Xi H; Shen W; Zhang K; Li J; Liang W; Hu C; Wei B; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Oct; 18(10):1051-5. PubMed ID: 26499155
[TBL] [Abstract][Full Text] [Related]
23. [Down-expression of FOXA2 in gastric adenocarcinoma].
Zhang Z; Sun J; Bai Z; Li H; He S; Chen R; Che X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 May; 31(5):672-6. PubMed ID: 25940296
[TBL] [Abstract][Full Text] [Related]
24. Analysis of a cytoskeleton-associated kinase PEAK1 and E-cadherin in gastric cancer.
Guo Q; Qin W; Li B; Yang H; Guan J; Liu Z; Li S
Pathol Res Pract; 2014 Dec; 210(12):793-8. PubMed ID: 25445115
[TBL] [Abstract][Full Text] [Related]
25. An immunohistochemical study of E-cadherin expression with correlations to clinicopathological features in gastric cancer.
Shun CT; Wu MS; Lin JT; Wang HP; Houng RL; Lee WJ; Wang TH; Chuang SM
Hepatogastroenterology; 1998; 45(22):944-9. PubMed ID: 9755986
[TBL] [Abstract][Full Text] [Related]
26. Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers.
Boo YJ; Park SS; Kim JH; Mok YJ; Kim SJ; Kim CS
J Surg Oncol; 2007 Feb; 95(2):110-7. PubMed ID: 17066436
[TBL] [Abstract][Full Text] [Related]
27. Plasma expression of the intestinal metaplasia markers CDH17 and TFF3 in patients with gastric cancer.
Choi B; Lee HJ; Min J; Choe HN; Choi YS; Son YG; Ahn HS; Suh YS; Goldenring JR; Yang HK
Cancer Biomark; 2017 Jul; 19(3):231-239. PubMed ID: 28453457
[TBL] [Abstract][Full Text] [Related]
28. [Correlation of E-cadherin hypermethylation to tumorigenesis and development of gastric cancer].
Liu WT; Jiao HL; Yang YL; Wang D; Zhang WM
Ai Zheng; 2007 Nov; 26(11):1199-203. PubMed ID: 17991318
[TBL] [Abstract][Full Text] [Related]
29. [Expression of KAI1/CD82, E-cadherin and integrin beta-1 and their relationship with tumor invasion and metastasis in gastric cancer].
Liu J; Yang GF; Gong LL; Liu H; Xiong YY
Zhonghua Bing Li Xue Za Zhi; 2007 Aug; 36(8):558-9. PubMed ID: 17980107
[No Abstract] [Full Text] [Related]
30. T-cadherin association with clinicopathological features and prognosis in axillary lymph node-positive breast cancer.
Kong DD; Yang J; Li L; Wang W; Chen YN; Wang SB; Zhou YZ
Breast Cancer Res Treat; 2015 Feb; 150(1):119-26. PubMed ID: 25677746
[TBL] [Abstract][Full Text] [Related]
31. Expression of liver-intestine cadherin and its correlation with lymph node metastasis in gastric cancer: can it predict N stage preoperatively?
Park SS; Kang SH; Park JM; Kim JH; Oh SC; Lee JH; Chae YS; Kim SJ; Kim CS; Mok YJ
Ann Surg Oncol; 2007 Jan; 14(1):94-9. PubMed ID: 17063305
[TBL] [Abstract][Full Text] [Related]
32. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
[TBL] [Abstract][Full Text] [Related]
33. Prognostic use of growth characteristics of early gastric cancer and expression patterns of apoptotic, cell proliferation, and cell adhesion proteins.
Pan W; Ishii H; Ebihara Y; Gobe G
J Surg Oncol; 2003 Feb; 82(2):104-10. PubMed ID: 12561066
[TBL] [Abstract][Full Text] [Related]
34. [Expression and clinical significance of KiSS-1 and E-cadherin in gastric cardia carcinoma].
Wang ZH; Feng XS; Wang GP; Gao SG; Mi JQ; Sun JT; Qu ZF; Han J; Zhang L
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 Jul; 10(4):380-2. PubMed ID: 17659469
[TBL] [Abstract][Full Text] [Related]
35. [Relationship of expression unbalance of matrix metalloproteinase and tissue inhibitor of metalloproteinase to invasiveness and metastasis in gastric carcinomas].
Li L; Zhang S; Lin H; Lin JY
Ai Zheng; 2002 Mar; 21(3):305-10. PubMed ID: 12452001
[TBL] [Abstract][Full Text] [Related]
36. [Expressions of Jumonji domain containing protein 2C and hypoxia-inducible factor-1α in gastric carcinoma and their clinical significance].
Xu Y; Yao HB; Jin Y; Ma YY; Wang HJ; Shao QS
Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(42):3375-8. PubMed ID: 24418035
[TBL] [Abstract][Full Text] [Related]
37. Tumor budding and E-cadherin expression are useful predictors of nodal involvement in T1 esophageal squamous cell carcinoma.
Nakagawa Y; Ohira M; Kubo N; Yamashita Y; Sakurai K; Toyokawa T; Tanaka H; Muguruma K; Shibutani M; Yamazoe S; Kimura K; Nagahara H; Amano R; Ohtani H; Yashiro M; Maeda K; Hirakawa K
Anticancer Res; 2013 Nov; 33(11):5023-9. PubMed ID: 24222146
[TBL] [Abstract][Full Text] [Related]
38.
Fujiwara K; Tsuji AB; Sudo H; Sugyo A; Akiba H; Iwanari H; Kusano-Arai O; Tsumoto K; Momose T; Hamakubo T; Higashi T
Ann Nucl Med; 2020 Jan; 34(1):13-23. PubMed ID: 31605356
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Significance of Dickkopf-1 in Gastric Cancer Survival: A Meta-Analysis.
Liu QR; Li YF; Deng ZQ; Cao JQ
Genet Test Mol Biomarkers; 2016 Apr; 20(4):170-5. PubMed ID: 27023747
[TBL] [Abstract][Full Text] [Related]
40. The diagnostic and clinicopathological value of trefoil factor 3 in patients with gastric cancer: a systematic review and meta-analysis.
Zhang CX; Wu CT; Xiao L; Tang SH
Biomarkers; 2021 Mar; 26(2):95-102. PubMed ID: 33401971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]